2-tert-butylhydroquinone has been researched along with fluorouracil in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barbour, KW; Berger, FG; Wang, G; Wang, Q; Zhang, X; Zhou, B | 1 |
| Deng, S; Li, J; Li, L; Wu, D; Xu, Y | 1 |
2 other study(ies) available for 2-tert-butylhydroquinone and fluorouracil
| Article | Year |
|---|---|
Drug screening assay based on the interaction of intact Keap1 and Nrf2 proteins in cancer cells.
Topics: Antimetabolites, Antineoplastic; Cell Line, Tumor; Drug Evaluation, Preclinical; Floxuridine; Fluorescence Resonance Energy Transfer; Fluorouracil; Green Fluorescent Proteins; Humans; Hydroquinones; Kelch-Like ECH-Associated Protein 1; Luminescent Proteins; NF-E2-Related Factor 2; Protein Binding; Recombinant Fusion Proteins; Red Fluorescent Protein | 2019 |
TBHQ attenuates ferroptosis against 5-fluorouracil-induced intestinal epithelial cell injury and intestinal mucositis via activation of Nrf2.
Topics: Animals; Cell Death; Cell Line; Cytokines; Diarrhea; Disease Models, Animal; Epithelial Cells; Ferroptosis; Fluorouracil; Humans; Hydroquinones; Interleukin-1beta; Intestines; Male; Mice; Mice, Inbred C57BL; Mucositis; NF-E2-Related Factor 2; Tumor Necrosis Factor-alpha | 2021 |